Alliance Global Partners Upgrades Qualigen Therapeutics (QLGN) to Buy
Tweet
Share
E-mailGet Alerts QLGN Hot Sheet
Price: $3.21 --0%
Rating Summary:
1 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
1 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Alliance Global Partners analyst James Molloy upgraded Qualigen Therapeutics (NASDAQ: QLGN) from Hold to Buy with a price target of $10.00.
For an analyst ratings summary and ratings history on Qualigen Therapeutics click here. For more ratings news on Qualigen Therapeutics click here.
Shares of Qualigen Therapeutics closed at $4.70 yesterday.
You May Also Be Interested In
- Freedom Broker Upgrades Serve Robotics (SERV) to Buy
- Jefferies Upgrades Minerva Neurosciences (NERV) to Buy
- CIBC Upgrades PRO REIT (PRV-U:CN) to Outperformer
Create E-mail Alert Related Categories
UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
